The implied dysregulated RKIP-hypoxia axis in cancer and immune evasion: Clinical implications
- 29 November 2025
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 85, 101328
Abstract
No abstract availableKeywords
Funding Information
- Jonsson Comprehensive Cancer Center, University of California, Los Angeles
This publication has 392 references indexed in Scilit:
- Hypoxia: Intriguing Feature in Cancer Cell BiologyChemMedChem, 2024
- miR‐155‐5p and miR‐760 mediate radiation therapy suppressed malignancy of non‐small cell lung cancer cellsBioFactors, 2019
- Hypoxia induces myeloid‐derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C‐C motif) ligand 26Hepatology, 2016
- Hypoxia‐inducible factor 3‐alpha expression is associated with the stable chondrocyte phenotypeJournal of Orthopaedic Research, 2015
- Nuclear factor kappa B–mediated CD47 up‐regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in miceHepatology, 2015
- Cellular and molecular mechanisms in the hypoxic tissue: role of HIF‐1 and ROSCell Biochemistry and Function, 2013
- Negative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxiaJournal of Cellular Biochemistry, 2011
- Raf kinase inhibitor protein positively regulates cell–substratum adhesion while negatively regulating cell–cell adhesionJournal of Cellular Biochemistry, 2007
- Expression of hypoxia‐inducible factor‐1α is associated with tumor vascularization in human colorectal carcinomaInternational Journal of Cancer, 2003
- Molecular mechanisms of vasculogenesis and embryonic angiogenesisJournal of Cellular Physiology, 1997